A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Urinary Incontinence, Urge

Interventions

DRUG

oxybutynin

low dose oxybutynin administered daily

DRUG

oxybutynin

middle dose oxybutynin administered daily

DRUG

oxybutynin

high dose oxybutynin administered daily

Trial Locations (2)

SNBL Clinical Pharmacology Center, Baltimore

Advanced Biomedical Research, Hackensack

All Listed Sponsors

lead

FemmePharma Global Healthcare, Inc.

INDUSTRY

NCT00749632 - A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence | Biotech Hunter | Biotech Hunter